Genmab stock heads into the open after new share issue news
Published on 09/09/2026 at 04:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
At the close on September 8, 2026, Genmab stock showed the impact of fresh corporate actions, with investors digesting news of newly issued shares from employee warrant exercises and the upcoming extraordinary general meeting scheduled for October 7, 2026. According to market data, the stock ended that session with a modest move in its home market, while broader equity indices also traded cautiously amid mixed sentiment in global markets. The latest announcement of new shares and the convening of the extraordinary general meeting form the key backdrop as Genmab heads into today’s session.
September 8, 2026 in numbers
Genmab A/S (ISIN DK0010272202) reported that it will issue 28,011 new shares following the exercise of employee warrants, raising about DKK 44.3 million in cash proceeds and increasing its share capital by roughly 0.04 percent.Reuters The warrants were exercised at prices ranging from DKK 1,334.5 to DKK 1,948 per share, and after the transaction the company’s total share capital rises to DKK 62,405,855 shares, each carrying one vote.Reuters In the same session, Genmab shares closed at a level that reflected only a limited reaction to these warrant exercises, while its daily percentage change remained moderate compared with movements seen across major global indices.The Globe and Mail The stock’s performance on September 8, 2026 therefore came against a backdrop of cautious trading and only incremental dilution from the new share issuance.
Extraordinary general meeting and events today
Looking ahead, Genmab has convened an extraordinary general meeting for October 7, 2026 at 3:00 PM CEST in Valby, Denmark, with shareholders asked to vote on the Board of Directors’ remuneration for 2026.Genmab 6-K filing The registration date for participation is September 30, 2026, with attendance and proxy registrations due by October 2, 2026 and postal votes required by the morning of October 6, 2026.Genmab 6-K filing Ahead of today’s open, investors also register that global equity markets recently faced pressure from rising oil prices and geopolitical tensions, which weighed on benchmark indices during the most recent completed trading day and may continue to shape risk appetite in the broader market environment.Pittsburgh Post-Gazette market wrap
